Answers are grounded in this paper and cite their sources.
Machine learning predicts nonadherence and nonpersistence of treatment in older adults with rheumatoid arthritis, suggesting advancements in personalized medicine.
We developed ML models predicting nonadherence and nonpersistence of b/tsDMARDs for older adults with RA. There is potential to leverage ML for understanding patients' behavior of utilizing b/tsDMARDs treatment with a goal towards personalized medicine in RA.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: